These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease. Heilmann RM; Otoni CC; Jergens AE; Grützner N; Suchodolski JS; Steiner JM Vet Immunol Immunopathol; 2014 Oct; 161(3-4):184-92. PubMed ID: 25183017 [TBL] [Abstract][Full Text] [Related]
6. Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis. Nielsen OH; Gionchetti P; Ainsworth M; Vainer B; Campieri M; Borregaard N; Kjeldsen L Am J Gastroenterol; 1999 Oct; 94(10):2923-8. PubMed ID: 10520846 [TBL] [Abstract][Full Text] [Related]
7. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Kaiser T; Langhorst J; Wittkowski H; Becker K; Friedrich AW; Rueffer A; Dobos GJ; Roth J; Foell D Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327 [TBL] [Abstract][Full Text] [Related]
8. Total soluble and endogenous secretory receptor for advanced glycation endproducts (RAGE) in IBD. Meijer B; Hoskin T; Ashcroft A; Burgess L; Keenan JI; Falvey J; Gearry RB; Day AS J Crohns Colitis; 2014 Jun; 8(6):513-20. PubMed ID: 24291021 [TBL] [Abstract][Full Text] [Related]
9. The Circulating Level of Soluble Receptor for Advanced Glycation End Products Displays Different Patterns in Ulcerative Colitis and Crohn's Disease: A Cross-Sectional Study. Ciccocioppo R; Imbesi V; Betti E; Boccaccio V; Kruzliak P; Gallia A; Cangemi GC; Maffe GC; Vanoli A; Merante S; De Amici M; Falcone C; Klersy C; Corazza GR Dig Dis Sci; 2015 Aug; 60(8):2327-37. PubMed ID: 25757448 [TBL] [Abstract][Full Text] [Related]
10. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Leach ST; Yang Z; Messina I; Song C; Geczy CL; Cunningham AM; Day AS Scand J Gastroenterol; 2007 Nov; 42(11):1321-31. PubMed ID: 17852869 [TBL] [Abstract][Full Text] [Related]
11. Effect of faecal calprotectin assay variability on the management of inflammatory bowel disease and potential role of faecal S100A12. Whitehead SJ; Ford C; Gama RM; Ali A; McKaig B; Waldron JL; Steed H; Brookes MJ J Clin Pathol; 2017 Dec; 70(12):1049-1056. PubMed ID: 28735301 [TBL] [Abstract][Full Text] [Related]
12. Fecal S100A12: a novel noninvasive marker in children with Crohn's disease. de Jong NS; Leach ST; Day AS Inflamm Bowel Dis; 2006 Jul; 12(7):566-72. PubMed ID: 16804393 [TBL] [Abstract][Full Text] [Related]
13. The use of calgranulin-C (S100A12) and fecal zonulin as possible non-invasive markers in children with inflammatory bowel disease: a clinical study. Cenni S; Casertano M; Trani M; Pacella D; Martinelli M; Staiano A; Miele E; Strisciuglio C Eur J Pediatr; 2023 Mar; 182(3):1299-1308. PubMed ID: 36637538 [TBL] [Abstract][Full Text] [Related]
15. Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease. Zhang W; Teng G; Wu T; Tian Y; Wang H Inflamm Bowel Dis; 2017 Dec; 23(12):2134-2141. PubMed ID: 29084078 [TBL] [Abstract][Full Text] [Related]
16. Human S100A12: a novel key player in inflammation? Pietzsch J; Hoppmann S Amino Acids; 2009 Mar; 36(3):381-9. PubMed ID: 18443896 [TBL] [Abstract][Full Text] [Related]
17. B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease. Zhang P; Liu X; Guo A; Xiong J; Fu Y; Zou K Dig Dis Sci; 2016 Sep; 61(9):2608-18. PubMed ID: 27056038 [TBL] [Abstract][Full Text] [Related]
18. Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity. Yilmaz Y; Yonal O; Eren F; Atug O; Hamzaoglu HO J Crohns Colitis; 2011 Oct; 5(5):402-6. PubMed ID: 21939913 [TBL] [Abstract][Full Text] [Related]
19. Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Foell D; Kane D; Bresnihan B; Vogl T; Nacken W; Sorg C; Fitzgerald O; Roth J Rheumatology (Oxford); 2003 Nov; 42(11):1383-9. PubMed ID: 12832707 [TBL] [Abstract][Full Text] [Related]
20. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]